vimarsana.com

Verastem Oncology announced the initial interim safety and efficacy results from the ongoing RAMP 205 Phase 1/2 clinical trial evaluating avutometinib plus defactinib in combination with gemcitabine...

Related Keywords

Chicago ,Illinois ,United States ,American , ,Eastern Cooperative Oncology Group ,American Society Of Clinical Oncology ,Verastem Oncology ,American Society ,Clinical Oncology ,Annual Meeting ,Performance Status ,

© 2025 Vimarsana

vimarsana.com © 2020. All Rights Reserved.